GSK plc vs Harley-Davidson Inc — how do they compare? GSK plc trades at $50.5 (market cap $102.60B), while Harley-Davidson Inc trades at $26.91 (market cap $2.78B). The key difference: GSK plc is far larger — about 36.9× Harley-Davidson Inc's market cap, and GSK plc pays the higher dividend (3.57%). Which is the better fit depends on your goals.
| GSK | HOG | |
|---|---|---|
Market Cap | $102.60B | $2.78B |
Sector | Health | Consumer Cyclical |
52-Week High | $61.18 | $31.03 |
52-Week Low | $38.22 | $17.19 |
Enterprise Value | $123.04B | $3.19B |
Dividend Yield | 3.57% | 2.75% |
Trailing returns across standard periods
Latest headlines on both assets
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →Harley-Davidson is a global leading manufacturer of heavyweight motorcycles, merchandise, parts, and accessories. It sells custom, cruiser, and touring motorcycles and offers a complete line of Harley-Davidson motorcycle parts, accessories, riding gear, and apparel, as well as merchandise. Harley-Davidson Financial Services provides wholesale financing to dealers and retail financing and insurance brokerage services to customers. Harley has historically captured about half of all heavyweight domestic retail motorcycle registrations, a metric it had ceded in 2020 as it repositioned the business, but a level it is working back toward. In recent years the firm has expanded into the adventure touring market with its Pan America model and into electric with the LiveWire brand.
Read more on HOG →